Haemonetics (HAE) vs Teleflex (TFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Haemonetics (HAE) has outperformed Teleflex (TFX) over the past year, gaining 106.5% versus a loss of 1.9%. Over five years, HAE leads with a +45.5% price change compared with -65.7% for TFX. Haemonetics is the larger company by market cap ($5.27 billion vs $5.23 billion), about 1.0 times the size, while Teleflex is growing revenue faster (+17.2% vs -2.0%).
On valuation, Teleflex trades at a lower forward P/E (11.3x vs 20.0x for Haemonetics). Teleflex pays a dividend yielding 1.10%, while Haemonetics does not currently pay one. Haemonetics converts more of its revenue into profit, with a net margin of 7.3% versus -45.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HAE | TFX |
|---|---|---|
| Share price | $115.80 | $123.33 |
| Market cap | $5.27B | $5.23B |
| 1-day change | +13.85% | -0.93% |
| YTD return | +26.90% | +2.00% |
| 1-year return | +106.48% | -1.90% |
| 5-year return | +45.49% | -65.73% |
| P/E ratio (TTM) | 55.94 | — |
| Forward P/E | 20.04 | 11.26 |
| EPS (TTM) | $2.07 | $-8.48 |
| Dividend yield | 0.00% | 1.10% |
| Annual dividend | $0.00 | $1.36 |
| Revenue (latest FY) | $1.33B | $1.99B |
| Revenue growth (YoY) | -1.97% | +17.25% |
| Net income (latest FY) | $97.31M | $-905.64M |
| Gross margin | 59.04% | 56.24% |
| Operating margin | 11.75% | 5.94% |
| Net margin | 7.29% | -45.45% |
| 52-week high | $120.72 | $145.00 |
| 52-week low | $48.17 | $100.18 |
| Distance from 52-week high | -4.08% | -14.95% |
| Analyst consensus | buy | buy |
| Avg. price target upside | -3.71% | +25.46% |
| Average volume | 678.94K | 655.00K |
| Shares outstanding | 45.50M | 42.37M |
| Employees | 3,009 | 15,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HAE has outperformed TFX by 108.4 percentage points over the past year.
- Teleflex offers a meaningfully higher dividend yield (1.10% vs 0.00%).
- Haemonetics is more profitable, keeping 7.3 cents of every revenue dollar as net income versus -45.4 cents for Teleflex.
- Teleflex grew revenue faster in its latest fiscal year (+17.25% vs -1.97%).
About Haemonetics
HAE stock →Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments.
Health Care · Medical/Dental Instruments · 3,009 employees
About Teleflex
TFX stock →Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.
Health Care · Medical/Dental Instruments · 15,500 employees
HAE vs TFX FAQ
Which is bigger, Haemonetics or Teleflex?
Haemonetics (HAE) is larger, with a market capitalization of $5.27B compared with $5.23B for Teleflex (TFX).
Which stock has performed better over the past year, HAE or TFX?
HAE returned +106.48% over the past 12 months, compared with -1.90% for TFX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Haemonetics or Teleflex?
Teleflex pays a dividend yielding 1.10%, while Haemonetics does not currently pay a regular dividend.
Are Haemonetics and Teleflex in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.